Pre- and Postmortem Imaging of Transplanted Cells
Overview
Authors
Affiliations
Therapeutic interventions based on the transplantation of stem and progenitor cells have garnered increasing interest. This interest is fueled by successful preclinical studies for indications in many diseases, including the cardiovascular, central nervous, and musculoskeletal system. Further progress in this field is contingent upon access to techniques that facilitate an unambiguous identification and characterization of grafted cells. Such methods are invaluable for optimization of cell delivery, improvement of cell survival, and assessment of the functional integration of grafted cells. Following is a focused overview of the currently available cell detection and tracking methodologies that covers the entire spectrum from pre- to postmortem cell identification.
Cadaveric Stem Cells: Their Research Potential and Limitations.
Ciesla J, Tomsia M Front Genet. 2022; 12:798161.
PMID: 35003228 PMC: 8727551. DOI: 10.3389/fgene.2021.798161.
Gao Y, Jablonska A, Chu C, Walczak P, Janowski M Membranes (Basel). 2021; 11(7).
PMID: 34209565 PMC: 8305565. DOI: 10.3390/membranes11070484.
Mesenchymal Stem Cells for Neurological Disorders.
Andrzejewska A, Dabrowska S, Lukomska B, Janowski M Adv Sci (Weinh). 2021; 8(7):2002944.
PMID: 33854883 PMC: 8024997. DOI: 10.1002/advs.202002944.
Comparative strategies for stem cell biodistribution in a preclinical study.
Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y Acta Pharmacol Sin. 2019; 41(4):572-580.
PMID: 31705124 PMC: 7470780. DOI: 10.1038/s41401-019-0313-x.
Andrzejewska A, Jablonska A, Seta M, Dabrowska S, Walczak P, Janowski M Stem Cell Res Ther. 2019; 10(1):187.
PMID: 31238982 PMC: 6593614. DOI: 10.1186/s13287-019-1296-8.